首页> 美国卫生研究院文献>other >Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg Steroids and a Combination of Anticoagulants: A Case Report
【2h】

Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg Steroids and a Combination of Anticoagulants: A Case Report

机译:IVIg类固醇和抗凝剂联合治疗难治性肝素诱导的血小板减少合并脑静脉窦血栓形成:一例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Heparin-induced thrombocytopenia (HIT) type II is caused by antibody production that bind complexes between heparin and platelet factor 4 leading to platelet consumption and thrombosis. In a small subset of cases referred to as autoimmune HIT, the antibodies activate platelets even in the absence of heparin. Refractory HIT is a type of autoimmune HIT in which thrombocytopenia persists for weeks after heparin discontinuation and carries increased risk for thrombosis and more severe thrombocytopenia. We present a case of refractory HIT with cerebral venous sinus thrombosis (CVST) that was successfully treated with a change in anticoagulant alongside steroids and a second trial of intravenous immunoglobulin (IVIg).
机译:肝素诱导的II型血小板减少症(HIT)是由抗体产生引起的,该抗体结合肝素和血小板因子4之间的复合物,导致血小板消耗和血栓形成。在称为自身免疫性HIT的一小部分病例中,即使没有肝素,抗体也会激活血小板。难治性HIT是一种自身免疫性HIT,其中肝素停药后血小板减少症持续数周,并增加了血栓形成和更严重的血小板减少症的风险。我们介绍了难治性HIT伴脑静脉窦血栓形成(CVST)的病例,该治疗成功地与类固醇同时使用了抗凝剂的改变和静脉内免疫球蛋白(IVIg)的第二次试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号